PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+8.87%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.74B
AUM Growth
+$3.74B
(-2.1%)
Cap. Flow
-$171M
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
49.37%
Holding
148
New
23
Increased
20
Reduced
26
Closed
34
Top Buys
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$74.1M |
| 2 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$41.6M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
$33.9M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$24.2M |
| 5 |
DBVT
DBV Technologies
DBVT
|
$20.3M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$65.8M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$57.5M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$56.8M |
| 4 |
Humana
HUM
|
$38.3M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$35.2M |
Sector Composition
| 1 | Healthcare | 90.77% |
| 2 | Financials | 0.17% |
| 3 | Consumer Discretionary | 0.05% |
| 4 | Industrials | 0.03% |
| 5 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Humana
HUM
$37.5B
| $11.8M | 0.32% |
35,000
-113,218
| -76% | -$38.3M |
|
52
Wave Life Sciences
WVE
$1.27B
| $11.7M | 0.31% |
234,019
-48,779
| -17% | -$2.44M |
|
|
ABMD
53
DELISTED
Abiomed Inc
ABMD
| $10.7M | 0.29% |
23,800
-12,846
| -35% | -$5.78M |
|
|
MTEM
54
DELISTED
Molecular Templates, Inc.
MTEM
| $10.6M | 0.28% |
131,609
+83,333
| +173% | +$6.74M |
|
|
AMRN
55
Amarin Corp
AMRN
$311M
| $9.93M | 0.27% |
+30,510
| New | +$9.93M |
|
56
TherapeuticsMD
TXMD
$12.8M
| $9.84M | 0.26% |
+30,000
| New | +$9.84M |
|
|
MRNS
57
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $9.08M | 0.24% |
226,933
| – | – |
|
|
ADMS
58
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $8.45M | 0.23% |
422,015
-662,144
| -61% | -$13.3M |
|
|
TSRO
59
DELISTED
TESARO, Inc.
TSRO
| $7.8M | 0.21% |
200,000
+100,000
| +100% | +$3.9M |
|
60
CareDx
CDNA
$678M
| $7.52M | 0.2% |
260,676
-207,000
| -44% | -$5.97M |
|
61
Arrowhead Research
ARWR
$3.84B
| $7.01M | 0.19% |
365,445
| – | – |
|
|
EIDX
62
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $6.86M | 0.18% |
686,922
| – | – |
|
|
PTE
63
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $6.43M | 0.17% |
+13,473
| New | +$6.43M |
|
64
eHealth
EHTH
$126M
| $6.39M | 0.17% |
+226,220
| New | +$6.39M |
|
|
OMED
65
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $5.56M | 0.15% |
2,620,897
| – | – |
|
|
UROV
66
DELISTED
Urovant Sciences Ltd.
UROV
| $5.55M | 0.15% |
+462,659
| New | +$5.55M |
|
|
SRRA
67
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $5.44M | 0.15% |
80,000
-32,500
| -29% | -$2.21M |
|
|
ABEOW
68
DELISTED
Abeona Therapeutics Inc. Warrant
ABEOW
| $5.15M | 0.14% |
659,636
-600,000
| -48% | -$4.68M |
|
|
TBIO
69
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $5M | 0.13% |
500,000
| – | – |
|
|
CLVS
70
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.41M | 0.12% |
+150,000
| New | +$4.41M |
|
71
Neuronetics
STIM
$216M
| $4.35M | 0.12% |
135,500
+10,000
| +8% | +$321K |
|
|
ACHN
72
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $3.68M | 0.1% |
1,000,000
| – | – |
|
73
Xeris Biopharma Holdings
XERS
$1.27B
| $3.53M | 0.09% |
200,627
-249,373
| -55% | -$4.38M |
|
74
Evolent Health
EVH
$1.11B
| $3.12M | 0.08% |
110,000
+40,000
| +57% | +$1.14M |
|
75
Abeona Therapeutics
ABEO
$356M
| $3.08M | 0.08% |
9,618
+7,232
| +303% | +$2.31M |
|